Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The genetic fingerprint of susceptibility for transplant-associated thrombotic microangiopathy.

Blood - 25 Feb 2016

Jodele Sonata, Zhang Kejian, Zou Fanggeng, Laskin Benjamin, Dandoy Christopher E, Myers Kasiani C, Lane Adam, Meller Jaroslav, Medvedovic Mario, Chen Jenny, Davies Stella M

Abstract excerpt

Transplant-associated thrombotic microangiopathy (TA-TMA) occurs frequently after hematopoietic stem cell transplantation (HSCT) and can lead to significant morbidity and mortality. There are no data addressing individual susceptibility to TA-TMA. We performed a hypothesis-driven analysis of 17 candidate genes known to play a role in complement activation as part of a prospective study of TMA in HSCT recipients....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adolescent
Share to Child

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Child, Preschool

Share to Hematopoietic Stem Cell Transplantation

Share to High-Throughput Nucleotide Sequencing

Share to Infant

Share to Kaplan-Meier Estimate

Share to Transcriptome

Source

Open in PubMed Open full text

Identifiers

PMID: 26603840
DOI: 10.1182/blood-2015-08-663435
PMCID: PMC4828073

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The genetic fingerprint of susceptibility for transplant-associated thrombotic microangiopathy.PMID 26603840Read ↗

Genetic Factors and the Outcomes of Transplant-Associated Thrombotic MicroangiopathiesSemantic proximity Read ↗

Pretransplant Genetic Susceptibility: Clinical Relevance in Transplant-Associated Thrombotic Microangiopathy.Semantic proximity Read ↗

Early Elevation of Complement Factor Ba Is a Predictive Biomarker for Transplant-Associated Thrombotic Microangiopathy.Semantic proximity Read ↗

Developing a genetic testing panel for evaluation of morbidities in kidney transplant recipients.Semantic proximity Read ↗

Genetic testing of complement and coagulation pathways in patients with severe hypertension and renal microangiopathy.Semantic proximity Read ↗

Epidemiology, Outcomes, and Complement Gene Variants in Secondary Thrombotic Microangiopathies.Semantic proximity Read ↗

Single Nucleotide Polymorphisms in CD40L Predict Endothelial Complications and Mortality After Allogeneic Stem-Cell Transplantation.Semantic proximity Read ↗

Interferon-complement loop in transplant-associated thrombotic microangiopathySemantic proximity Read ↗

Abnormalities in the alternative pathway of complement in children with hematopoietic stem cell transplant-associated thrombotic microangiopathy.Semantic proximity Read ↗

Genetic variations and transplant outcomes.Semantic proximity Read ↗

Small vessels, big trouble in the kidneys and beyond: hematopoietic stem cell transplantation–associated thrombotic microangiopathySemantic proximity Read ↗

Functional and Genetic Landscape of Complement Dysregulation Along the Spectrum of Thrombotic Microangiopathy and its Potential Implications on Clinical OutcomesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.